• Exchange: SIX Swiss Ex
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Cytos Biotechnology AG

+ Add to Watchlist


0.15 CHF 0.01 6.25%

As of 09:21:11 ET on 10/21/2014.

Snapshot for Cytos Biotechnology AG (CYTN)

Open: 0.17 Day's Range: 0.15 - 0.17 Volume: 38,606
Previous Close: 0.16 52wk Range: 0.09 - 3.90 1-Yr Rtn: -96.00%

Stock Chart for CYTN

No chart data available.
  • CYTN:SW 0.16
  • 1D
  • 1M
  • 1Y
Interactive CYTN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CYTN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SMI -
Earnings Per Share (CHF) (ttm) -
Est. EPS (CHF) (12/2014) -0.9150
Est. PEG Ratio -
Market Cap (M CHF) 4.58
Shares Outstanding (M) 30.53
30 Day Average Volume 226,521
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/31/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CYTN

  • Revenue
  • Net Income (M/CHF)
  • Profit Margin (%)

Company Profile & Key Executives for CYTN

Cytos Biotechnology AG develops and produces biopharmaceuticals. The Company produces vaccines that immunize the patient against disease related proteins. This instructs the immune system to produce antibodies to reverse or prevent disease progression. Cytos develops treatments for immunology and inflammation disorders, cancer and cardiovascular, nervous system, and infectious diseases.

Christian ItinChairman/CEOHarry WeltenExec VP/CFO
Matthias AlderExec VP:Corporate DevelopmentFrank HenneckeExec VP:Product Dev
More Company Profile & Key Executives for CYTN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil